Claudia Marcela Granados Rugeles

Claudia Marcela Granados Rugeles

Auto-generated profile, based on publicly available information

Claudia Marcela Granados Rugeles

Pontificia Universidad Javeriana Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Cr. 7 #40‐62, 2nd Floor Bogotá Colombia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
MFMarta Roqué i Figuls
Marta Roqué i Figuls
MGMaria Giné-Garriga
Maria Giné-Garriga
CRClaudia Granados Rugeles
Claudia Granados Rugeles
CPCarla Perrotta
Carla Perrotta
JVJordi Vilaró
Jordi Vilaró

10 December 2014 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
MRMaria Ximena Rojas-Reyes
Maria Ximena Rojas-Reyes
CRClaudia Granados Rugeles
Claudia Granados Rugeles
LCLaura Patricia Charry-Anzola
Laura Patricia Charry-Anzola

20 January 2016 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
IFIvan Florez
Ivan Florez
DKDr.Reem Al Khalifah
Dr.Reem Al Khalifah
JSJavier M. Sierra
Javier M. Sierra
CGClaudia M. Granados
Claudia M. Granados
JYJuan José Yepes-Nuñez
Juan José Yepes-Nuñez
LTLehana Thabane
Lehana Thabane
Acute diarrhea and acute gastroenteritis (AD/AGE) are common among children in low- and middle-income countries (LMIC) and high-income countries (HIC). Supportive therapy including maintaining feeding, prevention of dehydration, and use of oral rehydration solution (ORS), is the mainstay of treatment in all children. Several additional treatments aiming to reduce the episode duration have been compared to placebo, but the differences in effectiveness among them are unknown. We will conduct a systematic review of all randomized controlled trials evaluating the use of zinc, vitamin A, probiotics, prebiotics, synbiotics, racecadotril, smectite, and fermented and lactose-free milk/formula for AD/AGE treatment in children. The primary outcomes are diarrhea duration and mortality. Secondary outcomes are diarrhea lasting 3 or 7 days, stool frequency, treatment failure, hospitalizations, and adverse events. We will search MEDLINE, Ovid EMBASE, CINAHL, the Cochrane Central Register of Controlled Trials (CENTRAL), and LILACS through Ovid, as well as grey literature resources. Two reviewers will independently screen titles and abstracts, review full texts, extract information, and assess the risk of bias (ROB) and the confidence in the estimate (with the grading of recommendations, assessment, development, and evaluation [GRADE] approach). Results will be summarized narratively and statistically. Subgroup analysis according to HIC vs. LMIC, age, nutrition status, and ROB is planned. We will perform a Bayesian network meta-analysis to combine the pooled direct and indirect treatment effect estimates for each outcome, if adequate data is available. This is the first systematic review and network meta-analysis that aims to determine the relative effectiveness of pharmacological and nutritional treatments for reducing the duration of AD/AGE in children. The results will help to reduce the uncertainty of the effectiveness of the interventions, find knowledge gaps, and/or encourage further research for other therapeutic options. PROSPERO registration number: CRD42015023778.

23 December 2021 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
PDF file
GCGinna Cabra‐Bautista
Ginna Cabra‐Bautista
CRClaudia Marcela Granados Rugeles
Claudia Marcela Granados Rugeles
CGCarlos Fernando Grillo-Ardila
Carlos Fernando Grillo-Ardila
FLFabián Armando Gil Laverde
Fabián Armando Gil Laverde

1 December 2015 in Value in Health Regional Issues
Verified
Journal Article
Closed access
SASara Atehortúa
Sara Atehortúa
IFIvan Florez
Ivan Florez
MCMateo Ceballos
Mateo Ceballos
CGClaudia Granados
Claudia Granados
LOLuis E. Orozco
Luis E. Orozco
AMAurelio Mejía
Aurelio Mejía

17 May 2023 in Colombian Journal of Anesthesiology
Verified
Journal Article
Open access
PDF file
PSPaula Angélica Suárez-Álvarez
Paula Angélica Suárez-Álvarez
CGClaudia Marcela Granados-Rugeles
Claudia Marcela Granados-Rugeles
CRCarlos Javier Rincón-Rodríguez
Carlos Javier Rincón-Rodríguez
Frequency, association and impact measures are key concepts in clinical epidemiology; however, it has been found that a considerable proportion of health students and professionals have no knowledge of how to use or interpret them when reading a scientific paper or conducting research. This article aims to explain the main epidemiological measures, how they are used, derived and interpreted. They are approached from the perspective of each of the most frequently used types of primary quantitative research studies (randomized clinical trials, cohort studies, case-control estudies and cross-sectional studies) in order to provide the reader with the context in which they are used. Moreover, the process for calculating and interpreting each result in a real setting is explained using clinical examples for a better understanding of these concepts and in order to prevent their use from becoming just a mechanical or repetitive exercise.